Panasonic Holdings Corporation
Panasonic Holdings Corporation PCRFF Peers
See (PCRFF) competitors and their performances in Stock Market.
Peer Comparison Table: Consumer Electronics Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PCRFF | $10.98 | -2.58% | 25.6B | 8.32 | $1.32 | +2.82% |
| SSNLF | $42.33 | +9.01% | 277.5B | 8.80 | $4.81 | +1.85% |
| XIACF | $6.78 | -1.98% | 175.9B | 52.18 | $0.13 | N/A |
| XIACY | $33.99 | -1.82% | 175.3B | 53.11 | $0.64 | N/A |
| SNEJF | $28.06 | +6.42% | 169.1B | 21.26 | $1.32 | +0.48% |
| SWDHY | $11.00 | +3.38% | 27.2B | 10.78 | $1.02 | N/A |
| PCRFY | $9.36 | -1.27% | 21.8B | 6.59 | $1.42 | N/A |
| KYOCY | $11.88 | -0.34% | 16.7B | 99.00 | $0.12 | +0.28% |
| KYOCF | $10.42 | -22.93% | 14.7B | 86.83 | $0.12 | +3.25% |
| JVCZY | $46.62 | +18.06% | 6.9B | 15.70 | $2.97 | +0.88% |
Stock Comparison
PCRFF vs SSNLF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, SSNLF has a market cap of 277.5B. Regarding current trading prices, PCRFF is priced at $10.98, while SSNLF trades at $42.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas SSNLF's P/E ratio is 8.80. In terms of profitability, PCRFF's ROE is +0.08%, compared to SSNLF's ROE of +0.09%. Regarding short-term risk, PCRFF is more volatile compared to SSNLF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs XIACF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, XIACF has a market cap of 175.9B. Regarding current trading prices, PCRFF is priced at $10.98, while XIACF trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas XIACF's P/E ratio is 52.18. In terms of profitability, PCRFF's ROE is +0.08%, compared to XIACF's ROE of +0.08%. Regarding short-term risk, PCRFF is more volatile compared to XIACF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs XIACY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, XIACY has a market cap of 175.3B. Regarding current trading prices, PCRFF is priced at $10.98, while XIACY trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas XIACY's P/E ratio is 53.11. In terms of profitability, PCRFF's ROE is +0.08%, compared to XIACY's ROE of +0.11%. Regarding short-term risk, PCRFF is more volatile compared to XIACY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs SNEJF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, SNEJF has a market cap of 169.1B. Regarding current trading prices, PCRFF is priced at $10.98, while SNEJF trades at $28.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas SNEJF's P/E ratio is 21.26. In terms of profitability, PCRFF's ROE is +0.08%, compared to SNEJF's ROE of +0.14%. Regarding short-term risk, PCRFF is more volatile compared to SNEJF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs SWDHY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, SWDHY has a market cap of 27.2B. Regarding current trading prices, PCRFF is priced at $10.98, while SWDHY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas SWDHY's P/E ratio is 10.78. In terms of profitability, PCRFF's ROE is +0.08%, compared to SWDHY's ROE of +0.07%. Regarding short-term risk, PCRFF is less volatile compared to SWDHY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs PCRFY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, PCRFY has a market cap of 21.8B. Regarding current trading prices, PCRFF is priced at $10.98, while PCRFY trades at $9.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas PCRFY's P/E ratio is 6.59. In terms of profitability, PCRFF's ROE is +0.08%, compared to PCRFY's ROE of +0.05%. Regarding short-term risk, PCRFF is more volatile compared to PCRFY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs KYOCY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, KYOCY has a market cap of 16.7B. Regarding current trading prices, PCRFF is priced at $10.98, while KYOCY trades at $11.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas KYOCY's P/E ratio is 99.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to KYOCY's ROE of +0.01%. Regarding short-term risk, PCRFF is more volatile compared to KYOCY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs KYOCF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, KYOCF has a market cap of 14.7B. Regarding current trading prices, PCRFF is priced at $10.98, while KYOCF trades at $10.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas KYOCF's P/E ratio is 86.83. In terms of profitability, PCRFF's ROE is +0.08%, compared to KYOCF's ROE of +0.03%. Regarding short-term risk, PCRFF is more volatile compared to KYOCF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs JVCZY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, JVCZY has a market cap of 6.9B. Regarding current trading prices, PCRFF is priced at $10.98, while JVCZY trades at $46.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas JVCZY's P/E ratio is 15.70. In terms of profitability, PCRFF's ROE is +0.08%, compared to JVCZY's ROE of +0.10%. Regarding short-term risk, PCRFF is less volatile compared to JVCZY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs SHCAF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, SHCAF has a market cap of 3.4B. Regarding current trading prices, PCRFF is priced at $10.98, while SHCAF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas SHCAF's P/E ratio is 13.53. In terms of profitability, PCRFF's ROE is +0.08%, compared to SHCAF's ROE of +0.24%. Regarding short-term risk, PCRFF is more volatile compared to SHCAF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs TCLHF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, TCLHF has a market cap of 3.4B. Regarding current trading prices, PCRFF is priced at $10.98, while TCLHF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas TCLHF's P/E ratio is 15.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to TCLHF's ROE of +0.05%. Regarding short-term risk, PCRFF is more volatile compared to TCLHF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs SHCAY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, SHCAY has a market cap of 3.1B. Regarding current trading prices, PCRFF is priced at $10.98, while SHCAY trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas SHCAY's P/E ratio is 11.80. In terms of profitability, PCRFF's ROE is +0.08%, compared to SHCAY's ROE of -1.06%. Regarding short-term risk, PCRFF is more volatile compared to SHCAY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs CSIOF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, CSIOF has a market cap of 1.9B. Regarding current trading prices, PCRFF is priced at $10.98, while CSIOF trades at $8.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas CSIOF's P/E ratio is 46.44. In terms of profitability, PCRFF's ROE is +0.08%, compared to CSIOF's ROE of +0.05%. Regarding short-term risk, PCRFF is more volatile compared to CSIOF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs CSIOY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, CSIOY has a market cap of 1.7B. Regarding current trading prices, PCRFF is priced at $10.98, while CSIOY trades at $73.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas CSIOY's P/E ratio is 30.23. In terms of profitability, PCRFF's ROE is +0.08%, compared to CSIOY's ROE of +0.05%. Regarding short-term risk, PCRFF is more volatile compared to CSIOY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs AITUY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, AITUY has a market cap of 1.4B. Regarding current trading prices, PCRFF is priced at $10.98, while AITUY trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas AITUY's P/E ratio is 21.49. In terms of profitability, PCRFF's ROE is +0.08%, compared to AITUY's ROE of +0.05%. Regarding short-term risk, PCRFF is more volatile compared to AITUY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs SNCPF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, SNCPF has a market cap of 957.5M. Regarding current trading prices, PCRFF is priced at $10.98, while SNCPF trades at $43.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas SNCPF's P/E ratio is 8.01. In terms of profitability, PCRFF's ROE is +0.08%, compared to SNCPF's ROE of +0.02%. Regarding short-term risk, PCRFF is more volatile compared to SNCPF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs SWDHF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, SWDHF has a market cap of 936.7M. Regarding current trading prices, PCRFF is priced at $10.98, while SWDHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas SWDHF's P/E ratio is 6.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to SWDHF's ROE of +0.06%. Regarding short-term risk, PCRFF is more volatile compared to SWDHF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs BGOUF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, BGOUF has a market cap of 299.8M. Regarding current trading prices, PCRFF is priced at $10.98, while BGOUF trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas BGOUF's P/E ratio is -34.33. In terms of profitability, PCRFF's ROE is +0.08%, compared to BGOUF's ROE of -0.06%. Regarding short-term risk, PCRFF is more volatile compared to BGOUF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs ADPXY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, ADPXY has a market cap of 117.8M. Regarding current trading prices, PCRFF is priced at $10.98, while ADPXY trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas ADPXY's P/E ratio is -13.36. In terms of profitability, PCRFF's ROE is +0.08%, compared to ADPXY's ROE of +1.75%. Regarding short-term risk, PCRFF is more volatile compared to ADPXY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs VTEPF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, VTEPF has a market cap of 92.2M. Regarding current trading prices, PCRFF is priced at $10.98, while VTEPF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas VTEPF's P/E ratio is -0.43. In terms of profitability, PCRFF's ROE is +0.08%, compared to VTEPF's ROE of -0.29%. Regarding short-term risk, PCRFF is more volatile compared to VTEPF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs CHWTF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, CHWTF has a market cap of 81.9M. Regarding current trading prices, PCRFF is priced at $10.98, while CHWTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas CHWTF's P/E ratio is -0.50. In terms of profitability, PCRFF's ROE is +0.08%, compared to CHWTF's ROE of -0.13%. Regarding short-term risk, PCRFF is more volatile compared to CHWTF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs HLOC Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, HLOC has a market cap of 69.4M. Regarding current trading prices, PCRFF is priced at $10.98, while HLOC trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas HLOC's P/E ratio is -16.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to HLOC's ROE of +0.50%. Regarding short-term risk, PCRFF is more volatile compared to HLOC. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs DBOXF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, DBOXF has a market cap of 48.6M. Regarding current trading prices, PCRFF is priced at $10.98, while DBOXF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas DBOXF's P/E ratio is 21.90. In terms of profitability, PCRFF's ROE is +0.08%, compared to DBOXF's ROE of +0.30%. Regarding short-term risk, PCRFF is more volatile compared to DBOXF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs HAPBF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, HAPBF has a market cap of 23M. Regarding current trading prices, PCRFF is priced at $10.98, while HAPBF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas HAPBF's P/E ratio is -4.50. In terms of profitability, PCRFF's ROE is +0.08%, compared to HAPBF's ROE of +2.21%. Regarding short-term risk, PCRFF is more volatile compared to HAPBF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs AMOSF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, AMOSF has a market cap of 31.4K. Regarding current trading prices, PCRFF is priced at $10.98, while AMOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas AMOSF's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.08%, compared to AMOSF's ROE of -8.40%. Regarding short-term risk, PCRFF is more volatile compared to AMOSF. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs NUHRF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, NUHRF has a market cap of 27.1K. Regarding current trading prices, PCRFF is priced at $10.98, while NUHRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas NUHRF's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to NUHRF's ROE of -3.48%. Regarding short-term risk, PCRFF is less volatile compared to NUHRF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs GAXY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, GAXY has a market cap of 23.3K. Regarding current trading prices, PCRFF is priced at $10.98, while GAXY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas GAXY's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to GAXY's ROE of +4.24%. Regarding short-term risk, PCRFF is more volatile compared to GAXY. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs COLCF Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, COLCF has a market cap of 8.3K. Regarding current trading prices, PCRFF is priced at $10.98, while COLCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas COLCF's P/E ratio is -0.04. In terms of profitability, PCRFF's ROE is +0.08%, compared to COLCF's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to COLCF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs ANDR Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, ANDR has a market cap of 6.8K. Regarding current trading prices, PCRFF is priced at $10.98, while ANDR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas ANDR's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.08%, compared to ANDR's ROE of +0.13%. Regarding short-term risk, PCRFF is more volatile compared to ANDR. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs BZIC Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, BZIC has a market cap of 6.8K. Regarding current trading prices, PCRFF is priced at $10.98, while BZIC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas BZIC's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.08%, compared to BZIC's ROE of +1.77%. Regarding short-term risk, PCRFF is more volatile compared to BZIC. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs NGEY Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, NGEY has a market cap of 5.7K. Regarding current trading prices, PCRFF is priced at $10.98, while NGEY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas NGEY's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to NGEY's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to NGEY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs CTXV Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, CTXV has a market cap of 2.5K. Regarding current trading prices, PCRFF is priced at $10.98, while CTXV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas CTXV's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to CTXV's ROE of +0.68%. Regarding short-term risk, PCRFF is less volatile compared to CTXV. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs PUMD Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, PUMD has a market cap of 1.9K. Regarding current trading prices, PCRFF is priced at $10.98, while PUMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas PUMD's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to PUMD's ROE of +0.90%. Regarding short-term risk, PCRFF is more volatile compared to PUMD. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs ZVTK Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, ZVTK has a market cap of 1.4K. Regarding current trading prices, PCRFF is priced at $10.98, while ZVTK trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas ZVTK's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to ZVTK's ROE of +0.00%. Regarding short-term risk, PCRFF is less volatile compared to ZVTK. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs GAXYQ Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, GAXYQ has a market cap of 1.2K. Regarding current trading prices, PCRFF is priced at $10.98, while GAXYQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas GAXYQ's P/E ratio is -0.00. In terms of profitability, PCRFF's ROE is +0.08%, compared to GAXYQ's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to GAXYQ. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs LTEC Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, LTEC has a market cap of 486. Regarding current trading prices, PCRFF is priced at $10.98, while LTEC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas LTEC's P/E ratio is -0.01. In terms of profitability, PCRFF's ROE is +0.08%, compared to LTEC's ROE of -2.97%. Regarding short-term risk, PCRFF is more volatile compared to LTEC. This indicates potentially higher risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs CYRD Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, CYRD has a market cap of 343. Regarding current trading prices, PCRFF is priced at $10.98, while CYRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas CYRD's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to CYRD's ROE of N/A. Regarding short-term risk, PCRFF is less volatile compared to CYRD. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.
PCRFF vs NYXO Comparison
PCRFF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRFF stands at 25.6B. In comparison, NYXO has a market cap of 242. Regarding current trading prices, PCRFF is priced at $10.98, while NYXO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRFF currently has a P/E ratio of 8.32, whereas NYXO's P/E ratio is N/A. In terms of profitability, PCRFF's ROE is +0.08%, compared to NYXO's ROE of +5.00%. Regarding short-term risk, PCRFF is less volatile compared to NYXO. This indicates potentially lower risk in terms of short-term price fluctuations for PCRFF.